Medical device company GATT Technologies has closed €10.5m (US$11.4m) Series B financing led by US-based healthcare investor NGI. Johnson & Johnson Innovation – JJDC also participated along with Oost NL. At the same time, the company appointed Geert van Gansewinkel as its new chief executive officer and Vlad Hogenhuis as a new board member. Van…
©2023 All rights reserved LaingBuisson 
 Series B financing led by US-based healthcare investor NGI.){kind=link}